Immediate Impact
1 by Nobel laureates 62 standout
Citing Papers
Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Works of Ioannis Lilis being referenced
IκB Kinase α Is Required for Development and Progression of KRAS -Mutant Lung Adenocarcinoma
2018
Nrf2 Is Commonly Activated in Papillary Thyroid Carcinoma, and It Controls Antioxidant Transcriptional Responses and Viability of Cancer Cells
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ioannis Lilis | 221 | 88 | 43 | 124 | 117 | 26 | 442 | |
| Ryota Kurimoto | 201 | 90 | 41 | 112 | 113 | 30 | 431 | |
| Ning Jiang | 185 | 66 | 40 | 69 | 142 | 18 | 422 | |
| Rania H. Younis | 262 | 40 | 55 | 101 | 145 | 34 | 497 | |
| Hsi Chin Wu | 214 | 203 | 58 | 123 | 129 | 22 | 496 | |
| Bicheng Yong | 170 | 103 | 94 | 89 | 110 | 15 | 419 | |
| Libin Yang | 243 | 35 | 40 | 160 | 65 | 29 | 448 | |
| Guipeng Ding | 178 | 42 | 45 | 69 | 109 | 25 | 456 | |
| Jian‐Ching Wu | 252 | 32 | 45 | 110 | 72 | 18 | 455 | |
| Yanhong Liu | 173 | 31 | 30 | 93 | 94 | 30 | 473 | |
| José M. Muñoz‐Félix | 280 | 88 | 58 | 65 | 79 | 25 | 500 |
All Works
Login with ORCID to disown or claim papers
Loading papers...